Duncan Barbara Gayle - Insider Non-Derivative Transactions at Atea Pharmaceuticals, Inc. (AVIR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 20, 2025, Duncan Barbara Gayle's relationship to Atea Pharmaceuticals, Inc. (AVIR) is Director, and currently has 62,750 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AVIR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Duncan Barbara Gayle - Insider Non-Derivative Transactions of AVIR Common Stock

Duncan Barbara Gayle - Insider Non-Derivative Transactions at AVIR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 21, 2025	M -- (Common Stock)	29600	0	62750
Jun 17, 2024	M -- (Common Stock)	33150	0	33150